Year of Publication Titlesort ascending Faculty Association
2016 Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain. Frank Porreca, PhD
2012 Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy. John M. Streicher, PhD
2015 Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2022 Discovery of Levesquamide B through Global Natural Product Social Molecular Networking. Christopher Cartmell
2014 Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2011 Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2015 Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2012 Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues. John M. Streicher, PhD
2012 Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis. Roberta Diaz Brinton, Ph.D
2014 Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury.
2014 Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides.
2008 Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells.
2011 Development of potent μ and δ opioid agonists with high lipophilicity. Frank Porreca, PhD, Todd Vanderah, PhD
2021 Development of N,O-Carboxymethyl Chitosan-Starch Biomaterial Inks for 3D Printed Wound Dressing Applications. Christopher Cartmell
2013 Development of functionally selective, small molecule agonists at kappa opioid receptors. John M. Streicher, PhD
2021 Development of a microbe domestication pod (MD Pod) for in situ cultivation of micro-encapsulated marine bacteria. Christopher Cartmell
2020 Development of 3D Printed Drug-Eluting Scaffolds for Preventing Piercing Infection. Christopher Cartmell
2002 Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate.
2023 Development and evaluation of a pre-clerkship spiral curriculum: data from three medical school classes. Todd Vanderah, PhD
2019 Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light. Mohab M. Ibrahim, PhD, MD, Frank Porreca, PhD, Todd Vanderah, PhD
1995 Detecting differences in 5-methylcytosine using restriction enzyme isoschizomers: an endogenous control for complete digestion.
2015 Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs.
2022 Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery. Sally Dickinson, Ph.D.
2015 Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2021 Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain. Edita Navratilova, Frank Porreca, PhD